Case Letter

Pityriasis Rubra Pilaris Triggered by Photodynamic Therapy With Response to Tumor Necrosis Factor α–Blocking Agents and Acitretin

Anna López-Ferrer, MD, PhD; Joan Dalmau, MD; María Teresa Fernández-Figueras, MD, PhD; Lluís Puig, MD, PhD

Pityriasis rubra pilaris is a papulosquamous disease that shares histologic and clinical features with psoriasis, and it occasionally has been reported to be aggravated by UVB therapy. Tumor necrosis factor α inhibitors may be useful for the treatment of photoaggravated PRP, though other causes of widespread papulosquamous eruptions with lymphocytic infiltrates should be ruled out prior to initiating therapy.


 

Recommended Reading

Calcipotriene/ betamethasone dipropionate for psoriasis cut health care costs
Psoriasis Collection
VIDEO: Coffee Break 1: What did you learn at the meeting?
Psoriasis Collection
Psoriasis: The Story Worsens
Psoriasis Collection
VIDEO: Coffee Break 2: What did you learn at the meeting?
Psoriasis Collection
VIDEO: Are those musculoskeletal symptoms psoriatic arthritis?
Psoriasis Collection
VIDEO: Take the ‘whole’ approach to treating psoriasis patients
Psoriasis Collection
VIDEO: How to evaluate the need for systemic psoriasis therapy
Psoriasis Collection
VIDEO: Don’t overlook the signs of psoriatic arthritis
Psoriasis Collection
Gut-joint connection promising in psoriatic arthritis
Psoriasis Collection
Comorbidities: The List Grows
Psoriasis Collection

Related Articles